Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

M H Rubenstein1, L C Harrell, B V Sheynberg

  • 1Cardiac Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

Circulation
|January 11, 2000
PubMed

Insights

Patients with renal failure undergoing percutaneous coronary intervention have higher risks but improved outcomes with new devices. Stenting and debulking techniques enhance success rates for these complex patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Patients with end-stage renal disease (ESRD) face challenges with conventional balloon angioplasty.
  • This includes reduced procedural success and increased complication rates.

Purpose of the Study:

  • To evaluate immediate and long-term outcomes of percutaneous coronary intervention (PCI) in patients with varying degrees of renal failure.
  • To assess the impact of modern devices on these outcomes.

Main Methods:

  • A comparative study of 362 renal failure patients (creatinine >1.5 mg/dL) and 2972 patients with normal renal function.
  • Data collected between 1994 and 1997, comparing immediate and long-term outcomes.
  • Statistical analysis included logistic regression and Cox regression.

Main Results:

  • Renal failure patients were older with more comorbidities, showing reduced procedural success (89.5% vs 92.9%) and higher in-hospital major adverse cardiac events (MACEs) (10.8% vs 1.8%).
  • Renal failure was an independent predictor of MACEs (OR, 3.41).
  • Long-term follow-up revealed lower survival (27.7% vs 6.1%) and greater MACE rates (51% vs 33%) in renal failure patients. Dialysis and non-dialysis patients had similar outcomes.

Conclusions:

  • Despite increased risks, PCI in renal failure patients can achieve high procedural success rates with modern devices.
  • Stenting and debulking techniques significantly improve both immediate and long-term outcomes in this population.
  • Renal failure remains a significant predictor of adverse cardiac events post-PCI.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.3K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827